1 Simon, JA, Hodgkins, ML, Browner, WS, Neuhaus, JM, Bernert, JT Jr & Hulley, SB (1995) Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 142, 469–476.
2 Albert, CM, Campos, H, Stampfer, MJ, Ridker, PM, Manson, JE, Willett, WC & Ma, J (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346, 1113–1118.
3 Lemaitre, RN, King, IB, Mozaffarian, D, Kuller, LH, Tracy, RP & Siscovick, DS (2003) n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 77, 319–325.
4 MacLean, CH, Newberry, SJ, Mojica, WA, et al. (2006) Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403–415.
5 Holub, BJ, Bakker, DJ & Skeaff, CM (1987) Alterations in molecular species of cholesterol esters formed via plasma lecithin-cholesterol acyltransferase in human subjects consuming fish oil. Atherosclerosis 66, 11–18.
6 Blonk, MC, Bilo, HJ, Nauta, JJ, Popp-Snijders, C, Mulder, C & Donker, AJ (1990) Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr 52, 120–127.
7 Leaf, DA, Connor, WE, Barstad, L & Sexton, G (1995) Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes. Am J Clin Nutr 62, 68–73.
8 Katan, MB, Deslypere, JP, van Birgelen, AP, Penders, M & Zegwaard, M (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012–2022.
9 Andersen, LF, Solvoll, K & Drevon, CA (1996) Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 64, 305–311.
10 Hjartaker, A, Lund, E & Bjerve, KS (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 51, 736–742.
11 Burdge, GC, Jones, AE & Wootton, SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 88, 355–363.
12 Burdge, GC & Wootton, SA (2002) Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88, 411–420.
13 Pawlosky, R, Hibbeln, J, Lin, Y & Salem, N Jr (2003) n-3 Fatty acid metabolism in women. Br J Nutr 90, 993–994.
14 Pawlosky, RJ, Hibbeln, JR, Lin, Y, Goodson, S, Riggs, P, Sebring, N, Brown, GL & Salem, N Jr (2003) Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am J Clin Nutr 77, 565–572.
15 Dewailly, E, Blanchet, C, Lemieux, S, Sauve, L, Gingras, S, Ayotte, P & Holub, BJ (2001) n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74, 464–473.
16 Dewailly, EE, Blanchet, C, Gingras, S, Lemieux, S, Sauve, L, Bergeron, J & Holub, BJ (2001) Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74, 603–611.
17 Tavendale, R, Lee, AJ, Smith, WC & Tunstall-Pedoe, H (1992) Adipose tissue fatty acids in Scottish men and women: results from the Scottish Heart Health Study. Atherosclerosis 94, 161–169.
18 Dewailly, E, Blanchet, C, Gingras, S, Lemieux, S & Holub, BJ (2002) Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 76, 85–92.
19 Cambien, F, Warnet, JM, Vernier, V, Ducimetiere, P, Jacqueson, A, Flament, C, Orssaud, G, Richard, JL & Claude, JR (1988) An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol 127, 75–86.
20 Quigley, R & Watts, C (1997) Food Comes First: Methodologies for National Nutrition Survey of New Zealand. Wellington: Ministry of Health.
21 Russell, DG, Parnell, WR & Wilson, NC, (1997) NZ Food: NZ People. Key Results of the 1997 National Nutrition Survey. Wellington: Ministry of Health.
22 Parnell, WR, Wilson, NC & Russell, DG (2001) Methodology of the 1997 New Zealand National Nutrition Survey. N Z Med J 114, 123–126.
23 Crowe, FL, Skeaff, CM, Green, TJ & Gray, AR (2006) Serum fatty acids as biomarkers of fat intake predict serum cholesterol concentrations in a population-based survey of New Zealand adolescents and adults. Am J Clin Nutr 83, 887–894.
24 Bligh, EG & Dyer, WJ (1959) A rapid method of total lipids extractions and purification. Can J Biochem Physiol 37, 911–917.
25 Royston, P, Ambler, G & Sauerbrei, W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28, 964–974.
26 Quigley, RJ, Burlingame, BA, Milligan, GC & Gibson, JJ (1995) Fats and Fatty Acids in New Zealand Foods. Palmerston North: New Zealand Institute for Crop & Food Research.
27 Howe, P, Meyer, B, Record, S & Baghurst, K (2006) Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 22, 47–53.
28 Welch, AA, Bingham, SA, Ive, J, Friesen, MD, Wareham, NJ, Riboli, E & Khaw, KT (2006) Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr 84, 1330–1339.
29 Bakewell, L, Burdge, GC & Calder, PC (2006) Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 96, 93–99.
30 Brossard, N, Croset, M, Pachiaudi, C, Riou, JP, Tayot, JL & Lagarde, M (1996) Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr 64, 577–586.
31 Stark, KD & Holub, BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 79, 765–773.
32 Rees, D, Miles, EA, Banerjee, T, Wells, SJ, Roynette, CE, Wahle, KW & Calder, PC (2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 83, 331–342.
33 Yep, YL, Li, D, Mann, NJ, Bode, O & Sinclair, AJ (2002) Bread enriched with microencapsulated tuna oil increases plasma docosahexaenoic acid and total omega-3 fatty acids in humans. Asia Pac J Clin Nutr 11, 285–291.
34 Calder, PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
35 Salem, N Jr, Litman, B, Kim, HY & Gawrisch, K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945–959.
36 Kojima, M, Wakai, K, Tokudome, S, et al. (2005) Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study. Am J Epidemiol 161, 462–471.